drugset / Trial / NCT01078376
A Comparative Single-Dose Pharmacokinetic (PK) and Safety Study of Azilsartan Medoxomil in Children With Hypertension and in Healthy Adults
Non-randomizedParallel-groupOpen-label
Summary
The purpose of this study was to assess the pharmacokinetics (PK) and safety of a single dose of azilsartan medoxomil in children with hypertension, and comparative PK in healthy adults.
Timeline
- Start
- 2010-05
- Primary completion
- 2013-07
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azilsartan medoxomil | Other / unclassified | 0.66 mg/kg | Oral |
| Subject | Azilsartan medoxomil | Other / unclassified | 20 mg | Oral |
| Subject | Azilsartan medoxomil | Other / unclassified | 60 mg | Oral |
| Subject | Azilsartan medoxomil | Other / unclassified | 80 mg | Oral |